Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: drsvelte who wrote (839)	5/14/1998 2:38:00 PM
From: Bob Trocchi	Respond to of 4634

drsvelte... FYI More on Dr. GoldsteinViagra/ZONA In today's Boston Globe, there was a very positive article about Viagra. In it, it cites Dr. Goldstein who lead the study. >>And there's more, says Dr. Irwin Goldstein, professor of urology at Boston University School of Medicine and lead author of the study, which was supported by grants from Pfizer, the manufacturer of Viagra. ''It enhanced orgasmic activity and overall sexual satisfaction,'' he says, ''while side effects are incredibly minimal.'' ''The measure of a drug's success is not only its initial sales but its renewal rates, and they have been awesome in drug stores,'' added Goldstein, who along with other authors has been a consultant for Pfizer and for other companies making products to treat erectile dysfunction. ''Now we know why. It's not only easier to take, it affects more broad aspects of the relationship.''<< The whole article is located at: boston.com So it seems that Dr. Goldstein is a consultant to several drug companies, not just ZONA. Bob T.